fig3
![The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future](https://image.oaes.cc/29034589-e30a-4598-82f4-38d0ab099eb7/4493.fig.3.jpg)
Figure 3. Weekly number of tests in pharmacies and general practitioners’ offices (A) and home data (C) collected before, during, and after the lockdown in Italy, and weekly frequency (%) of abnormal tests collected in the same settings and periods (B and D, respectively). Redrawn with permission[109].